Related Experiment Videos
Bone marrow histopathology in peripheral T-cell lymphomas
Ahmet Dogan1, William G Morice
1Department of Histopathology, University College London, London, UK. a.dogan@ucl.ac.uk
British Journal of Haematology
|October 6, 2004
Summary
Bone marrow biopsy is crucial for diagnosing Peripheral T-cell lymphomas (PTCL), assessing disease extent, and monitoring treatment. Histopathology varies by PTCL subtype, often requiring advanced studies for accurate diagnosis.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Peripheral T-cell lymphomas (PTCL) represent 10-15% of lymphoproliferative disorders in the West.
- Bone marrow biopsy is essential for PTCL diagnosis, staging, and treatment monitoring.
- PTCL bone marrow involvement patterns differ significantly based on World Health Organization (WHO) classification subtypes.
Purpose of the Study:
- To review the histopathology of bone marrow biopsies in PTCL.
- To correlate bone marrow findings with the latest WHO classification of PTCL.
- To highlight diagnostic challenges and the importance of integrating various clinical and pathological data.
Main Methods:
- Review of histopathological features of bone marrow biopsies in various PTCL entities.
- Correlation of findings with the current WHO classification.
- Discussion of immunohistochemical and molecular techniques aiding diagnosis.
Main Results:
- Bone marrow infiltration patterns in PTCL vary, including nodular, interstitial, and intrasinusoidal.
- Angioimmunoblastic T-cell lymphoma shows nodular/interstitial patterns; hepatosplenic T-cell lymphoma and LGL leukemia exhibit intrasinusoidal infiltration.
- Subtle pathological features and reactive changes can complicate diagnosis, necessitating ancillary studies.
Conclusions:
- Bone marrow biopsy is integral to PTCL management, with diverse histopathological presentations.
- Accurate PTCL diagnosis relies on integrating clinical, aspirate, biopsy findings, and advanced molecular/immunohistochemical studies.
- Understanding subtype-specific bone marrow involvement is key for effective PTCL diagnosis and patient care.